Combined Treatment with Low Concentrations of Decitabine and SAHA Causes Cell Death in Leukemic Cell Lines but Not in Normal Peripheral Blood Lymphocytes
Epigenetic therapy reverting aberrant acetylation or methylation offers the possibility to target preferentially tumor cells and to preserve normal cells. Combination epigenetic therapy may further improve the effect of individual drugs. We investigated combined action of demethylating agent decitab...
Main Authors: | Barbora Brodská, Aleš Holoubek, Petra Otevřelová, Kateřina Kuželová |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2013/659254 |
Similar Items
-
Decitabine and SAHA-Induced Apoptosis Is Accompanied by Survivin Downregulation and Potentiated by ATRA in p53-Deficient Cells
by: Barbora Brodská, et al.
Published: (2014-01-01) -
Group I p21-activated kinases in leukemia cell adhesion to fibronectin
by: Kateřina Kuželová, et al.
Published: (2021-01-01) -
Localization of AML-related nucleophosmin mutant depends on its subtype and is highly affected by its interaction with wild-type NPM.
by: Barbora Brodská, et al.
Published: (2017-01-01) -
Chemotherapy-Induced Survivin Regulation in Acute Myeloid Leukemia Cells
by: Petra Otevřelová, et al.
Published: (2021-01-01) -
NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization
by: Markéta Šašinková, et al.
Published: (2021-01-01)